INVESTOR ALERT: Investigation of Vascular Solutions, Inc. Announced by Glancy Binkow & Goldberg LLP

Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Vascular Solutions, Inc. (“Vascular Solutions” or the “Company”) (NASDAQ:VASC) concerning possible violations of federal securities laws. The investigation is focused on certain statements issued by Vascular Solutions concerning the Company’s operations and financial prospects.

Please contact Casey Sadler, at (310) 201-9150, or at shareholders@glancylaw.com to discuss this matter. If you inquire by email, please include your mailing address, telephone number and number of shares purchased.

Vascular Solutions provides various medical device solutions to interventional cardiologists, interventional radiologists, electro physiologists and vein specialists worldwide. The investigation is related to the Company’s November 13, 2014, announcement that the U.S. Attorney’s Office and the Consumer Protection Branch of the U.S. Department of Justice filed an indictment in the United States District Court for the Western District of Texas related to the Short Kit version of Vascular Solutions’ Vari-Lase product for the treatment of varicose veins in the leg.

According to the Company, the indictment follows a four-year investigation and alleges that members of Vascular Solutions’ sales force spoke to physicians about the use of the Vari-Lase Short Kit to treat varicose perforator veins in the leg, and that the treatment of a leg's perforator veins is outside the Short Kit’s labeled indications and therefore constitutes an “off-label” use. Following this news, Vascular Solutions shares declined as much as 20% in intraday trading on November 14, 2014.

If you purchased Vascular Solutions shares, if you have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Casey Sadler, Esquire, of Glancy Binkow & Goldberg LLP, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at (310) 201-9150, Toll Free at (888) 773-9224, by e-mail to shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.